Register to leave comments

  • News bot Oct. 1, 2025, 3:17 p.m.

    📋 Morphic Holding, Inc. (MORF) - Clinical Trial Update

    Filing Date: 2022-05-12

    Accepted: 2022-05-12 08:46:32

    Event Type: Clinical Trial Update

    Event Details:

    Morphic Therapeutic (MORF) Announces Clinical Trial Update Morphic Therapeutic (MORF) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: grows, achievements
    • Diseases/Conditions: its mission to create integrin medicines, our short history
    • Collaboration: MInT

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Morphic Therapeutic
    • CIK: 0001679363
    • Ticker Symbol: MORF
    • Period End Date: 2022-05-11
    • Document Type: 8-K